MedTrace Logo

High Flow Nasal Oxygen Therapy an Implementation Study in Pediatric Wards

NCT06715423 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 960

Last updated 2025-01-30

No results posted yet for this study

Summary

The purpose of this study is to prospectively evaluate the process of implementing HFNO in several MSF projects, varying according to geographical and programmatic contexts, population, health structures, human resources, and management. It will generate evidence on the operational feasibility (in terms of human resources, equipment, logistics and costs) of integrating HFNO into PICU standard of care, as well as on the users' and caregivers' perspectives on HFNO and on the children clinical outcomes observed where HFNO is implemented. This relevant information will guide MSF in the decision making of scaling up HFNO therapy in its projects.

Conditions

  • Moderate Respiratory Distress
  • Severe Respiratory Distress

Sponsors & Collaborators

  • MOH Afghanistan

    collaborator UNKNOWN

  • MOH Bangladesh

    collaborator UNKNOWN

  • MOH Sierra Leone

    collaborator UNKNOWN

  • MOH Yemen

    collaborator UNKNOWN

  • MSF Médecins Sans Frontières Belgium

    collaborator UNKNOWN

  • MSF Médecins Sans Frontières France

    collaborator UNKNOWN

  • Fisher and Paykel Healthcare

    collaborator INDUSTRY

  • Epicentre

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Afghanistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06715423 on ClinicalTrials.gov